Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Beneficial Ownership Report · SCHEDULE 13G/A

Medirom Healthcare Technologies Inc.

Beneficial Ownership Report

Filed Nov 16, 2026Accepted Nov 16, 2026, 5:47 PM ESTFiling CIK 2045681Accession 0002045681-26-000003
Share

Structured filing — SCHEDULE 13G/A

primary_doc.xml

Open full document ↗

Amendment · This filing reports the amendment as submitted.

Subject company

Company
Medirom Healthcare Technologies Inc.
Company CIK
0001819704
Street
2-3-1 DAIBA
Street (continued)
MINATO-KU
City
TOKYO
State / country code
M0
Postal code
135-0091

Statement details

Amendment number
1
Security class
American depositary shares, each representing one common share, no par value
Event date
08/25/2026
Rule designation
Rule 13d-1(c)

Reporting person 1

Name
Triple One Investment Partnership
Citizenship / organization
M0
Reporting person type
PN
Aggregate amount owned
66,540.00
Percent of class
0.8
Sole voting power
66,540.00
Shared voting power
0.00
Sole dispositive power
66,540.00
Shared dispositive power
0.00

Reporting person 2

Name
Kabushiki Kaisha CARPE DIEM
Citizenship / organization
M0
Reporting person type
CO
Aggregate amount owned
66,540.00
Percent of class
0.8
Sole voting power
66,540.00
Shared voting power
0.00
Sole dispositive power
66,540.00
Shared dispositive power
0.00

Reporting person 3

Name
Takao Shimura
Citizenship / organization
M0
Reporting person type
IN
Aggregate amount owned
66,540.00
Percent of class
0.8
Sole voting power
66,540.00
Shared voting power
0.00
Sole dispositive power
66,540.00
Shared dispositive power
0.00

Item 1

Issuer

Medirom Healthcare Technologies Inc.

Principal executive office address

2-3-1 DAIBA, MINATO-KU, TOKYO, JAPAN, 135-0091.

Item 2

Citizenship

(i) Japan (ii) Japan (iii) Japan

Filing person

This statement is filed by: (i) Triple One Investment Partnership (ii) Kabushiki Kaisha CARPE DIEM (iii) Takao Shimura

Principal business or residence address

Toranomon 33 Mori Building 3-8-21 Toranomon, Minato-ku Tokyo 105-0001, Japan

Item 3

Not applicable indication

Y

Item 4

Percent of class

Triple One Investment Partnership - 0.8% Kabushiki Kaisha CARPE DIEM - 0.8% Takao Shimura - 0.8% The percentages above are calculated based on 7,901,950 outstanding common shares of the Issuer. Following the cancellation of the convertible bond, no shares issuable upon conversion of the convertible bond are included in the calculation.

Amount beneficially owned

Triple One Investment Partnership - 66,540 Kabushiki Kaisha CARPE DIEM - 66,540 Takao Shimura - 66,540

Sole voting power

Triple One Investment Partnership - 66,540 Kabushiki Kaisha CARPE DIEM - 66,540 Takao Shimura - 66,540

Shared voting power

Triple One Investment Partnership - 0 Kabushiki Kaisha CARPE DIEM - 0 Takao Shimura - 0

Sole dispositive power

Triple One Investment Partnership - 66,540 Kabushiki Kaisha CARPE DIEM - 66,540 Takao Shimura - 66,540

Shared dispositive power

Triple One Investment Partnership - 0 Kabushiki Kaisha CARPE DIEM - 0 Takao Shimura - 0

Item 5

Ownership of 5% or less

Y

Item 6

Not applicable indication

Y

Item 7

Not applicable indication

Y

Item 8

Not applicable indication

Y

Item 9

Not applicable indication

Y

Item 10

Not applicable indication

N

Certifications

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

Signature 1

Reporting person
Triple One Investment Partnership
Signed
/s/ Takao Shimura
Title
Authorized Signatory
Date
11/17/2026

Signature 2

Reporting person
Kabushiki Kaisha CARPE DIEM
Signed
/s/ Takao Shimura
Title
Representative Director
Date
11/17/2026

Signature 3

Reporting person
Takao Shimura
Signed
/s/ Takao Shimura
Title
Individual
Date
11/17/2026

Filed exhibits

Company context

MEDIROM, a holistic healthcare company, operates 292 (as of Dec 31, 2025) relaxation salons across Japan, Re. Ra. Ku® being its leading brand, and provides healthcare services. In 2015, MEDIROM entered the health tech business and launched new healthcare programs using an on-demand training app called “Lav®”, which is developed by the Company. MEDIROM also entered the device business in 2020 and has developed a smart tracker “MOTHER Bracelet®”. In 2023, MEDIROM launched REMONY®, a remote monitoring system for corporate clients, and has received orders from a broad range of industries, including nursing care, transportation, construction, and manufacturing, among others. MEDIROM hopes that its diverse health-related product and service offerings will help it collect and manage healthcare data from users and customers and enable it to become a leader in big data in the healthcare industry. For more information, visit https://medirom.co.jp/en.

Current securities

Recent company filings

  1. 6-K filingNov 18, 2026
  2. 20-F filingNov 18, 2026
  3. 6-K filingOct 13, 2026
  4. SCHEDULE 13D/A - filed by Eguchi Kouji regarding Medirom Healthcare Technologies Inc.Aug 28, 2026
  5. 6-K filingAug 27, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.